The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 

 

This Article
-Abstract
-Full Text
Suntharalingam G et al. Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412. N Engl J Med 2006;355:1018-28. DOI: 10.1056/NEJMoa063842. Supplementary Audio

Interview with Ganesh Suntharalingam on the severe illness and treatment of the volunteers in the recent trial of the TGN1412 monoclonal antibody.

photograph of Ganesh Suntharalingam
 

Supplement to: Suntharalingam G et al. Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412. N Engl J Med 2006;355:1018-28. DOI: 10.1056/NEJMoa063842.

Dr. Ganesh Suntharalingam is the clinical director of intensive care at Northwick Park Hospital in London.

Rachel Gotbaum, the interviewer, is an independent producer based in Boston.


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.